Transition metal complexes with tetradentate Schiff bases (N2O2) obtained from salicylaldehyde: A review of their possible anticancer properties

LA Alfonso-Herrera, D Hernández-Romero… - Coordination Chemistry …, 2024 - Elsevier
Despite multiple advances in prevention and treatment, cancer remains a deadly disease
globally. From 1942 to the present day, chemotherapy has been recognized as one of the …

Characterization, DFT, and antimicrobial evaluation of some new N2O2 tetradentate Schiff base metal complexes

MS El‐Attar, FM Ahmed, SA Sadeek… - Applied …, 2022 - Wiley Online Library
Fe (III), Co (II), Ni (II), Cu (II), Y (III), Zr (IV), La (III), and U (VI) interact with Gat‐o‐phdn Schiff
base (4E, 4′ E)‐4, 4′‐(1, 2‐phenylenebis (azaneylylidene)) bis (1‐cyclopropyl‐6‐fluoro‐8 …

New tailored substituted benzothiazole Schiff base Cu (II)/Zn (II) antitumor drug entities: effect of substituents on DNA binding profile, antimicrobial and cytotoxic …

S Zehra, M Shavez Khan, I Ahmad… - Journal of Biomolecular …, 2019 - Taylor & Francis
New tailored Cu (II) & Zn (II) metal-based antitumor drug entities were synthesized from
substituted benzothiazole o‒vanillin Schiff base ligands. The complexes were thoroughly …

Evaluation of transition metal complexes of benzimidazole-derived scaffold as promising anticancer chemotherapeutics

A Hussain, MF AlAjmi, MT Rehman, AA Khan… - Molecules, 2018 - mdpi.com
Three new transition metal complexes, Cu (II) 1, Co (II) 2, and Zn (II) 3 with ligand “bimnap”
derived from 1-methyl-2-aminobenzimidazole and 2-hydroxynapthaldehyde were …

Mononuclear Co (II), Ni (II) and Cu (II) complexes of the Schiff base, 2-(((4-trifluoromethoxy) phenylimino) methyl)-6-tert-butylphenol: Synthesis, spectroscopic …

A Rambabu, N Ganji, S Daravath… - Journal of Molecular …, 2020 - Elsevier
Three mononuclear binary complexes, 1 [Co (L) 2 (H 2 O) 2], 2 [Ni (L) 2] and 3 [Cu (L) 2] with
Schiff base ligand, HL 2-((E)-(4-trifluoromethoxy) phenylimino) methyl)-6-tert-butylphenol, C …

Two novel homo/hetero polynuclear complexes for DNA binding, molecular docking and anti-cancer activity

S Cao, X Tai, K Li, A Zhang, P Ma, G Sui… - Journal of Molecular …, 2025 - Elsevier
Two novel polynuclear complexes [CuL (MeOH)] 2 Cu (1) and [CuL (OH 2)] 2 Ni (2) were
synthesized using a mononuclear copper complex (Na [CuL], where H 3 L=[N-(2-carboxy-4 …

Cu (II) complexes of a tridentate N, N, O-donor Schiff base of pyridoxal: synthesis, X-ray structures, DNA-binding properties and catecholase activity

S Mondal, M Chakraborty, A Mondal… - New Journal of …, 2018 - pubs.rsc.org
Two new Cu (II) complexes [Cu (L1)(N3)](1) and [Cu (L1)(NCS)] n (2), where HL1 ((E)-4-((2
(dimethylamino) ethylimino) methyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol) is an N, N, O …

Copper (II) salen-based complexes as potential anticancer agents

N Mohan, CV Vidhya, V Suni, JM Ameer… - New Journal of …, 2022 - pubs.rsc.org
In this work, we have systematically designed and synthesized four Cu (II) salen compounds
(1–4), which have been characterized using various spectroscopic and analytical …

DNA/Protein binding and anticancer activity of Zn (II) complexes based on azo-Schiff base ligands

Y Kumar, NK Singh, VD Singh, I Ali, RK Tiwari… - Inorganica Chimica …, 2022 - Elsevier
Synthesis of the azo–Schiff base ligands 2-((E)-((4-(diethylamino) phenyl) imino) methyl)-4-
((E)-(2-(phenylthio) phenyl) diazenyl) phenol (L1) and-((E)-((4-(diethylamino) phenyl)-imino) …

Copper (II) complexes as novel anticancer drug: Synthesis, spectral studies, crystal structures, in silico molecular docking and cytotoxicity

NA Mathews, MRP Kurup - Journal of Molecular Structure, 2022 - Elsevier
Three novel mixed ligand complexes of copper, derived from the parent
cyclohexylthiosemicarbazones were synthesized along with the secondary ligands such as …